Collegium Pharmaceutical Inc
NASDAQ:COLL
| Market Cap (Intraday) | 809.78M |
| Current PE | N/A |
| Forward PE | 4.11 |
| 2yr Forward PE | 3.12 |
| 10-Day MA | $24.15 |
| 50-Day MA | $26.65 |
| 200-Day MA | $20.95 |
Collegium Pharmaceutical Inc Stock, NASDAQ:COLL
100 Technology Center Drive, Suite 300, Stoughton, Massachusetts 02072
United States of America
Phone: +1.781.713.3699
Number of Employees: 207
Description
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.